References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Njar&Brodieetal(2015)DiscoveryanddevelopmentofGaleterone(TOK-001orVN/124-1)forthetreatmentofallstagesofprostatecancer.J.Med.Chem.582077PMID:25591066
Handrattaetal(2005)NovelC-17-heteroarylsteroidalCYP17inhibitors/antiandrogens:synthesis,invitrobiologicalactivity,pharmacokinetics,andantitumoractivityintheLAPC4humanprostatecancerxenograftmodel.J.Med.Chem.482972PMID:15828836
Keywords:Galeterone,supplier,CYP17,inhibitors,inhibits,androgen,receptors,antagonists,antagonsim,anticancer,TOK-001,VN/124-1,Cytochrome,P450,Androgen,Receptor,Cytochrome,P450,TocrisBioscience